IP Library Patent Application 10516944
Patent Application
App. No. 10/516,944

Transdermal absorption preparation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/516,944
Abstract

A transdermal absorption promotion composition comprising the following components (a), (b), and (c) and a transdermal absorption preparation comprising the following components (a), (b), (c), and (d) are disclosed. (a) propylene glycol (b) a polyol fatty acid ester (c) lauromacrogol (d) a drug component The transdermal absorption promotion composition and transdermal absorption preparation not only exhibit an excellent transdermal absorption promotion effect, but also exhibit superior skin-permeability, even if a drug having a relatively high lipophilic property and poor transdermal absorbability is used, exhibit a favorable feeling of use, and are safe and stable.

Claims (16)

1 . A transdermal absorption promotion composition comprising the following components (a), (b), and (c):

(a) propylene glycol,

(b) a polyol fatty acid ester, and

(c) lauromacrogol.

2 . The transdermal absorption promotion composition according to claim 1 , wherein the components (b) and (c) are mutually soluble with the component (a).

3 . The transdermal absorption promotion composition according to claim 1 or claim 2 , wherein the ratio of the total weight of the component (b) and component (c) to the weight of the component (a) is 0.01-99 and the weight ratio of the component (c) to the component (b) is 0.1-10.

4 . A transdermal absorption preparation comprising the following components (a), (b), (c), and (d):

(a) propylene glycol,

(b) a polyol fatty acid ester,

(c) lauromacrogol, and

(d) a drug component.

5 . The transdermal absorption preparation according to claim 4 , wherein the component (d) is a drug with comparatively high lipophilic properties.

6 . The transdermal absorption preparation according to claim 4 , wherein the preparation is in the form of an ointment, gel, cream, gel-like cream, liquid, lotion, aerosol, liniment, plaster, poultice, or reservoir-type patch.

7 . A homogeneous liquid preparation basically comprising the components (a) to (d).

8 . An oily ointment or oily cream preparation comprising the components (a) to (d) and an oily base.

9 . A method of promoting transdermal absorption of a drug in a transdermal absorption preparation comprising applying the transdermal absorption preparation of claim 4 to the skin.

Assignments (4)
MERGER Recorded May 4, 2007
From: HISAMITSU MEDICAL CO., LTD.
To: HISAMITSU PHARMACEUTICAL CO., INC.
Reel/Frame 019246/0969 →
CHANGE OF NAME Recorded Jun 14, 2005
From: BIOMEDIX CO., LTD.
To: HISAMITSU MEDICAL CO., LTD.
Reel/Frame 016323/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2005
From: SSP CO., LTD.
To: BIOMEDIX CO., LTD.
Reel/Frame 016004/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2005
From: NARUI, TAKASHI; OMICHI, KATSUHIRO; OKADA, MINORU; KURAZUMI, TOSHIAKI
To: SSP CO., LTD.
Reel/Frame 015713/0290 →